BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 29615050)

  • 1. Differential activity of methylene blue against erythrocytic and hepatic stages of Plasmodium.
    Bosson-Vanga H; Franetich JF; Soulard V; Sossau D; Tefit M; Kane B; Vaillant JC; Borrmann S; Müller O; Dereuddre-Bosquet N; Le Grand R; Silvie O; Mazier D
    Malar J; 2018 Apr; 17(1):143. PubMed ID: 29615050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.
    Eastman RT; Pattaradilokrat S; Raj DK; Dixit S; Deng B; Miura K; Yuan J; Tanaka TQ; Johnson RL; Jiang H; Huang R; Williamson KC; Lambert LE; Long C; Austin CP; Wu Y; Su XZ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):425-35. PubMed ID: 23129054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.
    Mustfa K; Landau I; Chabaud AG; Chavatte JM; Chandenier J; Duong TH; Richard-Lenoble D
    Sante; 2011; 21(3):133-42. PubMed ID: 22294247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo.
    Atamna H; Krugliak M; Shalmiev G; Deharo E; Pescarmona G; Ginsburg H
    Biochem Pharmacol; 1996 Mar; 51(5):693-700. PubMed ID: 8615907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylene blue induced morphological deformations in Plasmodium falciparum gametocytes: implications for transmission-blocking.
    Wadi I; Pillai CR; Anvikar AR; Sinha A; Nath M; Valecha N
    Malar J; 2018 Jan; 17(1):11. PubMed ID: 29310655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plant-derived morphinan as a novel lead compound active against malaria liver stages.
    Carraz M; Jossang A; Franetich JF; Siau A; Ciceron L; Hannoun L; Sauerwein R; Frappier F; Rasoanaivo P; Snounou G; Mazier D
    PLoS Med; 2006 Dec; 3(12):e513. PubMed ID: 17194195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid and Specific Action of Methylene Blue against
    Saison N; Franetich JF; Pinilla YT; Hoffmann A; Boussougou-Sambe ST; Ngossanga B; Tefit M; Ashraf K; Amanzougaghene N; Tajeri S; Adegnika AA; Mazier D; Borrmann S
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue.
    Adjalley SH; Johnston GL; Li T; Eastman RT; Ekland EH; Eappen AG; Richman A; Sim BK; Lee MC; Hoffman SL; Fidock DA
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):E1214-23. PubMed ID: 22042867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium yoelii: 17-kDa hepatic and erythrocytic stage protein is the target of an inhibitory monoclonal antibody.
    Charoenvit Y; Mellouk S; Sedegah M; Toyoshima T; Leef MF; De la Vega P; Beaudoin RL; Aikawa M; Fallarme V; Hoffman SL
    Exp Parasitol; 1995 May; 80(3):419-29. PubMed ID: 7729477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
    Delves M; Plouffe D; Scheurer C; Meister S; Wittlin S; Winzeler EA; Sinden RE; Leroy D
    PLoS Med; 2012 Feb; 9(2):e1001169. PubMed ID: 22363211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue schizontocidal effect of trifluoroacetyl primaquine in Plasmodium yoelii infected mice and Plasmodium cynomolgi infected monkeys.
    Shao BR; Ye XY
    Southeast Asian J Trop Med Public Health; 1991 Mar; 22(1):81-3. PubMed ID: 1948265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of invasive Plasmodium yoelii merozoites with a long half-life to evaluate invasion dynamics and potential invasion inhibitors.
    Mutungi JK; Yahata K; Sakaguchi M; Kaneko O
    Mol Biochem Parasitol; 2015 Nov; 204(1):26-33. PubMed ID: 26684675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of 25 quinolones and fluoroquinolones against liver and blood stage Plasmodium spp.
    Mahmoudi N; Ciceron L; Franetich JF; Farhati K; Silvie O; Eling W; Sauerwein R; Danis M; Mazier D; Derouin F
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2636-9. PubMed ID: 12878530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.
    Silvie O; Rubinstein E; Franetich JF; Prenant M; Belnoue E; Rénia L; Hannoun L; Eling W; Levy S; Boucheix C; Mazier D
    Nat Med; 2003 Jan; 9(1):93-6. PubMed ID: 12483205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Toll-Like Receptor 2 agonist PEG-Pam
    Ernest M; Hunja C; Arakura Y; Haraga Y; Abkallo HM; Zeng W; Jackson DC; Chua B; Culleton R
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):451-458. PubMed ID: 30396012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KAI407, a potent non-8-aminoquinoline compound that kills Plasmodium cynomolgi early dormant liver stage parasites in vitro.
    Zeeman AM; van Amsterdam SM; McNamara CW; Voorberg-van der Wel A; Klooster EJ; van den Berg A; Remarque EJ; Plouffe DM; van Gemert GJ; Luty A; Sauerwein R; Gagaring K; Borboa R; Chen Z; Kuhen K; Glynne RJ; Chatterjee AK; Nagle A; Roland J; Winzeler EA; Leroy D; Campo B; Diagana TT; Yeung BK; Thomas AW; Kocken CH
    Antimicrob Agents Chemother; 2014; 58(3):1586-95. PubMed ID: 24366744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of intravenous methylene blue, intravenous artesunate, and their combination in preclinical models of malaria.
    Ohrt C; Li Q; Obaldia N; Im-Erbsin R; Xie L; Berman J
    Malar J; 2014 Oct; 13():415. PubMed ID: 25336091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
    Puri SK; Singh N
    Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.